Pictet Asset Management Holding Sa Janux Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 656,605 shares of JANX stock, worth $15.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
656,605
Previous 384,797
70.64%
Holding current value
$15.6 Million
Previous $20.6 Million
13.95%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
193Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$265 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$109 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$86.6 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$78.9 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$55.6 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $987M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...